rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    CSBR
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      BioTech Breakthrough Acknowledges Champions Oncology Innovation with the "Contract Research and Development Innovation Award"
      Nov 10Yahoo FinanceCSBR
      Champions Oncology Q4 2026 Earnings Call Transcript - Champions Oncology (NASDAQ:CSBR)

      On Monday, Champions Oncology (NASDAQ:CSBR) discussed fourth-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensive

      Oct 8BenzingaCSBR
      Champions Oncology Q3 2026 Earnings Call Transcript - Champions Oncology (NASDAQ:CSBR)

      Champions Oncology (NASDAQ:CSBR) released third-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive

      Oct 8BenzingaCSBR
      Full Transcript: Champions Oncology Q1 2027 Earnings Call - Champions Oncology (NASDAQ:CSBR)

      On Thursday, Champions Oncology (NASDAQ:CSBR) discussed first-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensive

      Oct 8BenzingaCSBR
      Full Transcript: Champions Oncology Q4 2026 Earnings Call
      Sep 17BenzingaCSBR
      CSBR Stock Slips Post Q1 Earnings Despite Revenue, Margin Growth
      Sep 15Yahoo FinanceCSBR
      Champions Oncology Inc (CSBR) (Q1 2027) Earnings Call Highlights: Data Licensing Surge and ...

      Champions Oncology Inc (CSBR) posted 9% revenue growth, 50% gross margin, and record data licensing revenue in Q1 fiscal 2027.

      Sep 15Yahoo FinanceCSBR
      Champions Oncology Earnings Call Highlights Margin Momentum

      Detailed price information for Champions Oncolog (CSBR-Q) from The Globe and Mail including charting and trades.

      Sep 12The Globe and MailCSBR
      Champions Oncology (CSBR) Q1 2027 Earnings Call Transcript

      Motley Fool Press Release.

      Sep 11The Globe and MailCSBR
      Champions Oncology, Inc. Q1 2027 Earnings Call Summary

      Moby summary of Champions Oncology, Inc.'s Q1 2027 earnings call

      Sep 11Yahoo FinanceCSBR
      Champions Oncology Q1 Earnings Call Highlights

      Champions Oncology (NASDAQ:CSBR) reported first-quarter fiscal 2027 revenue growth, improved margins and its fifth consecutive quarter of positive adjusted EBITDA, as both its translational oncology services and data licensing businesses contributed to results. Revenue for the quarter totaled $15.2

      Sep 10Yahoo FinanceCSBR
      Earnings call transcript: Champions Oncology tops Q1 2027 estimates, shares slip
      Sep 10Investing.comCSBR
      Champions Oncology earnings beat by $0.06, revenue topped estimates
      Sep 10Investing.comCSBR
      Champions Oncology posts better-than-expected Q1, but shares edge lower on higher costs
      Sep 10Investing.comCSBR
      Champions Oncology Reports Revenue of $15.2 Million

      Oncology services margin improves to 51%; Adjusted EBITDA increases to $671,000HACKENSACK, NJ / ACCESS Newswire / September 10, 2026 / (Nasdaq:CSBR), a leading translational oncology research organization, today announced its financial results for its first quarter of fiscal 2027, ended July 31, 2026.First Quarter and Recent Highlights: * Revenue of $15.

      Sep 10Yahoo FinanceCSBR
      Champions Oncology to Announce First Quarter Financial Results on Thursday, September 10, 2026

      HACKENSACK, NJ / ACCESS Newswire / September 4, 2026 / (CSBR), a global leader in clinically relevant oncology research models and translational solutions, will report its financial and operational results for the quarter ended July 31, 2026, on Thursday, September 10, 2026, after market close. The company will host a conference call to discuss the results that day at 4:30 P.

      Sep 4Yahoo FinanceCSBR
      Champions Oncology Expands Integrated Radiopharmaceutical Development Platform with In-House SPECT/CT Imaging

      New molecular imaging capabilities connect longitudinal radiopharmaceutical uptake with biodistribution, efficacy and clinically annotated PDX tumor biology in a single, U.-based workflowHACKENSACK, NJ / ACCESS Newswire / September 1, 2026 / , a leading provider of translational oncology research solutions, today announced the expansion of its integrated radiopharmaceutical development platform with new in-house SPECT/CT imaging capabilities.

      Sep 1Yahoo FinanceCSBR

      This is the newest page. Registered accounts read further back.